AGNPF — Grey Matters Health Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1642178 ·
British Columbia, Canada
Last close
$0.31
Market Cap
$1.66M
52W High
$0.64
52W Low
$0.22
ADV30
7,541
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| May 2026 | 0 | — | -561,745 | -702,029 | 5,276,358 | 41,656 | 3,523,975 |
| Feb 2026 | 0 | — | -499,628 | -499,524 | 4,948,564 | 195,349 | 2,493,598 |
| Nov 2025 | 0 | — | -597,203 | -597,007 | 4,928,680 | 210,030 | 2,443,289 |
| Aug 2025 | 0 | — | -380,733 | -380,500 | 4,877,474 | 176,501 | 2,182,240 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,456,957
Investing CF
$155,204
Financing CF
$1,444,102
CapEx
$-19,796
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.64
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-31,889,095
Inventory
—
Receivables
$17,454
ST Investments
—
EBIT TTM
$-2,167,530
Pretax Income TTM
$-2,179,060
Interest Exp TTM
$12,077
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Aug 2025 | 0 | -1,717,794 | -1,717,055 | 4,877,474 | 2,182,240 | 2,695,234 | -1,157,041 |
| Aug 2024 | 0 | -2,412,042 | -502,982 | 3,944,040 | 1,775,447 | 2,168,593 | -2,709,577 |
| Aug 2023 | 0 | -5,241,991 | -6,781,200 | 4,193,699 | 2,719,760 | 1,473,939 | -2,553,008 |
| Aug 2022 | 0 | -6,019,955 | -6,054,356 | 8,140,757 | 2,516,099 | 5,624,658 | -2,912,741 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ATXI | AVENUE THERAPEUTICS, INC. | $1.65M | $0.50 | — |
| GCAN | TRAFALGAR INTERNATIONAL, INC. | $1.60M | $1.61 | — |
| RNAZ | Transcode Therapeutics, Inc. | $1.79M | $1.69 | — |
| LIFD | LFTD PARTNERS INC. | $1.48M | $0.10 | — |
| PPCB | Propanc Biopharma, Inc. | $1.44M | $0.63 | — |
News headlines (Yahoo Finance, 1h cache)
Grey Matters Announces the Closing of its Equity and Convertible Debenture Private Placement totalling CAD $1.12 Million
2026-09-23 11:00 · Yahoo
Grey Matters Announces an Increase to its Equity and Convertible Debenture Private Placement to CAD $1.1 Million
2026-09-16 11:00 · Yahoo
Grey Matters Closes First Tranche of $600,000 of its Equity and Convertible Debenture Private Placement
2026-09-10 11:00 · Yahoo
Grey Matters Achieves Final Major Milestone; Receives Radioactive Materials License from State of Florida for its Flagship NovaScan Neuroimaging Clinics™ Location
2026-08-20 13:08 · Yahoo
Grey Matters Announces CAD $800K of Private Placement Equity Financing and Convertible Debentures
2026-08-20 11:00 · Yahoo
Grey Matters Retains Nationally Recognized ProScan to Read Brain Images from its Flagship NovaScan Neuroimaging Clinics™ Location in Florida
2026-08-19 11:00 · Yahoo
Grey Matters Announces September Opening of its First Brain Dedicated PET Neuroimaging Clinic in the U.S.
2026-08-04 11:00 · Yahoo
Grey Matters Takes Delivery of the First Brain Dedicated PET Scanning System for its Flagship NovaScan Neuroimaging Clinic in Florida
2026-07-06 11:00 · Yahoo
Grey Matters closes $1.12M funding for Alzheimer's research
2026-09-23 13:00 · Yahoo
Grey Matters Health secures key Florida licence – ICYMI
2026-08-22 12:44 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.